UNIConnect’s Precision Mdx (Pmdxtm) Goes Live For Medcompgx; Partners with Translational Software to Integrate Multiple Systems in One Platform
Memphis, Tenn., Bellevue, Wash., and Salt Lake City (July 27, 2015) – MedCompGx, a division of MedComp Sciences based in Memphis, Tennessee, today announced the installation and implementation of UNIConnect’s Precision MDx (pMDxtm) laboratory information management system (LIMS) for its new genetic testing lab. The system is designed to provide comprehensive automation of all laboratory processes, while integrating with multiple systems under one umbrella. The installation of pMDx will help to advance MedCompGx’s mission to promote innovation in healthcare that creates better outcomes for patients by promoting healthy lifestyles through personalized medicine.
UNIConnect, MedCompGx and Translational Software will present a case study of the design and implementation at a news conference on Tuesday, July 28, 2015 at 11:00 AM (EDT) in Room B209 during the American Association of Clinical Chemistry (AACC) annual meeting at the Georgia World Conference Center in Atlanta, Georgia.
MedCompGx was founded to make personalized medicine a reality for all by integrating genetic analysis into everyday healthcare. Medical genetics has proven a powerful weapon in the treatment of disease, but can now be harnessed to individualize our approach to patient care and medication therapy.
“Our decision to partner with UNIConnect has been validated by the design and implementation process,” noted Dr. Jason Walker, chief geneticist at MedCompGx. “We are most impressed with the ease of this difficult multi-system integration, along with the company’s commitment to ongoing improvements and long-term partnership.”
Precision MDx (pMDx) has been developed for laboratory professionals seeking a focused solution for CAP/CLIA certified molecular laboratory operations. The software platform is ideal for MDx, CDx, NGS and PGx pursuits. It can be deployed as standalone software or integrated with existing LIS and billing infrastructure. Based on the powerful UNIFlow® Laboratory Process Management Platform, UNIConnect specializes in rapid implementation, allowing its users to accelerate time-to-market, and manage virtually any aspect of their go-to-market plans.
A key part of the success of the partnership has been the work accomplished by Translational Software, based in Bellevue, Washington. Translational Software is Software as a Solution (SaaS) company that is providing the pharmacogenetic interpretive solution for MedCompGx. By integrating the patient’s raw, genetic data with their individual medication list, MedCompGx is utilizing Translational Software’s proprietary knowledgebase to create actionable reports for the ordering clinicians. These reports can be used to identify problematic drug/gene interactions for the clinician in an easy-to-read, comprehensive report that will improve patient care.
“We are excited to work with MedCompGx in providing such important information for the healthcare community that they serve. By giving providers easy to read, accessible and actionable reports, they will be able to better manage their patient’s medications and help avoid costly adverse events,” commented Don Rule, chief executive officer, Translational Software.
UNIConnect’s pMDx system supports molecular diagnostic requirements across a wide range of entrepreneurial molecular test development companies and the institutional services of molecular pathology departments in community, private business, and academic medical centers. Core pMDx functionality also can be embedded with medical device manufacturers and integrates with legacy laboratory information systems.
“At UNIConnect, we believe that the success of both the science and business of personalized medicine begins in the laboratory,” said William Harten, president, UNIConnect. “If we can consistently improve laboratory processes and operations, we can help our clients to grow their businesses through improved service to clinicians and their patients.”
For more information about MedCompGx (www.medcompgx.com), Translational Software (www.translationalsoftware.com), and UNIConnect (www.uniconnect.com), please visit their booths at AACC ( UNIConnect at booth 5160 and Translational Software at booth 620).
About UNIConnect
UNIConnect supports the science and business of personalized medicine by delivering laboratory process management solutions for molecular laboratories and the organizations. The company’s technology adapts to rapid change, whether through scientific, regulatory or reimbursement dynamics, and the requirements of complex lab processes for the precise tracking and process detail required for molecular diagnostics, proteomics, clinical trials, etc. From the single lab to global network/enterprise, www.uniconnnect.com delivers critical capabilities that enable laboratories to achieve key objectives.
About MedCompGx
MedCompGx is committed to the idea that an individual’s unique genetic composition provides a blueprint for their health. Our cutting-edge approach allows us to help clinicians bring genetic information into their everyday patient care at an affordable price point. MedCompGx testing enables genetically informed prescribing practices to customize drug selection and dosing, which optimizes patient outcomes and reduces risk events. Genetics is now part of a holistic and evidence based approach to healthcare that empowers patients to realize the benefits of personalized medicine. Please visit www.MedCompGx.com to learn more.
About Translational Software
Translational Software is at the forefront of integrating genetic information into routine clinical care. The company’s Software as a Solution (SaaS) model generates relevant reports, based on complex testing data, for ordering clinicians with easy-to-understand recommendations and guidance on therapeutic options. The goal: enhance the health care professional’s diagnostic confidence, satisfaction and efficiency leading to better outcomes for the patient. Please visit www.translationalsoftware.com.
